Evidence map›Paper›PMID 38980411›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Synthesis, cytotoxicity, anti-inflammatory, anti-metastatic and anti-oxidant activities of novel chalcones incorporating 2-phenoxy-N-arylacetamide and thiophene moieties: induction of apoptosis in MCF7 and HEP2 cells.

Nada S Ibrahim, Hager Ahmed Sayed, Marwa Sharaky, Hadeer M Diab, Ahmed H M Elwahy, Ismail A Abdelhamid

Abstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nada S IbrahimDepartment of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza, 12613, Egypt.
Hager Ahmed SayedDepartment of Chemistry (Biochemistry Division), Faculty of Science, Cairo University, Giza, 12613, Egypt.
Marwa SharakyPharmacology unit, Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.
Hadeer M DiabDepartment of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt.
Ahmed H M ElwahyDepartment of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt. aelwahy@cu.edu.eg.
Ismail A AbdelhamidDepartment of Chemistry, Faculty of Science, Cairo University, Giza, 12613, Egypt. ismail_shafy@cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eight Novel chalcones were synthesized and their structures were confirmed by different spectral tools. All the prepared compounds were subjected to SRB cytotoxic screening against several cancer cell lines. Compound 5c exerted the most promising effect against MCF7 and HEP2 cells with IC

Indexed as

Anti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsApoptosisChalconesThiophenesAcetamidesCell CycleCell MovementHep G2 CellsHumansMCF-7 CellsMolecular Docking SimulationAcetamidesAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsChalconesThiophenesAnti-inflammatoryAnti-oxidantChalconesIntrinsic and extrinsic apoptosisWound healing

Identifiers

PMID38980411
PMCPMC11582173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.